Retraction

FTX Regulated miR-153-3p/FOXR2 to Promote Cisplatin Resistance in Ovarian Cancer

Citations (4)

4
Total Citations
1
Post-Retraction
(25.0%)
2
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
0 After 2+ years
212 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Deregulated circRNAs in Epithelial Ovarian Cancer With Activity in Preclinical<i>In Vivo</i>Models: Identification of Targets and New Modalities for Therapeutic Intervention
Ulrich H. Weidle, Fabian Birzele
Cancer Genomics & Proteomics Open Access
Published: Apr 2024
212 days after retraction
FOXN Transcription Factors: Regulation and Significant Role in Cancer
Jiali Song, Longshan Li, Fang Yang et al. (9 authors)
Molecular Cancer Therapeutics Open Access
Published: Jul 2023
3 citations
65 days before retraction
Retracted: FTX Regulated miR‐153‐3p/FOXR2 to Promote Cisplatin Resistance in Ovarian Cancer
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine Open Access
Published: Jan 2023
269 days before retraction
Quick Stats
Total Citations: 6
Years Since Retraction: 2.2 years
Open Access: Yes
Last Checked: Jul 24, 2025